Celine Marmion
#110,612
Most Influential Person Now
Researcher
Celine Marmion's AcademicInfluence.com Rankings
Celine Marmioncomputer-science Degrees
Computer Science
#12899
World Rank
#13823
Historical Rank
Computational Linguistics
#3224
World Rank
#3267
Historical Rank
Machine Learning
#5965
World Rank
#6062
Historical Rank
Artificial Intelligence
#6426
World Rank
#6540
Historical Rank
Download Badge
Computer Science
Celine Marmion's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Celine Marmion Influential?
(Suggest an Edit or Addition)According to Wikipedia, Celine J. Marmion is a Professor of Chemistry at the Royal College of Surgeons in Ireland and President of the Institute of Chemistry of Ireland. She is a Fellow of the Royal Society of Chemistry and the Institute of Chemistry of Ireland. Marmion is involved with the design of new chemotherapeutic drugs.
Celine Marmion's Published Works
Published Works
- Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens? (2019) (312)
- Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands (2004) (143)
- A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity. (2009) (95)
- Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision? (2017) (95)
- Copper complexes as artificial DNA metallonucleases: From Sigman’s reagent to next generation anti-cancer agent? (2017) (77)
- Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes. (2011) (66)
- A novel dual-functioning ruthenium(II)-arene complex of an anti-microbial ciprofloxacin derivative - Anti-proliferative and anti-microbial activity. (2016) (52)
- Enzyme inhibition as a key target for the development of novel metal-based anti-cancer therapeutics. (2010) (48)
- Hydroxamic acids are nitric oxide donors. Facile formation of ruthenium(II)-nitrosyls and NO-mediated activation of guanylate cyclase by hydroxamic acids (2000) (47)
- Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)]. (2012) (40)
- Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer. (2016) (40)
- Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity. (2011) (38)
- Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation (2008) (37)
- Hydroxamic Acids — An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands (2004) (33)
- Novel platinum(II) ammine hydroxamate and hydroximate complexes and the platinum-assisted hydrolysis of hydroxamic acids. (2005) (29)
- Ruthenium as an effective nitric oxide scavenger. (2004) (28)
- Monohydroxamic acids and bridging dihydroxamic acids as chelators to ruthenium(III) and as nitric oxide donors: syntheses, speciation studies and nitric oxide releasing investigations. (2008) (27)
- A novel platinum complex of the histone deacetylase inhibitor belinostat: rational design, development and in vitro cytotoxicity. (2013) (25)
- Novel platinum pyridinehydroxamic acid complexes: Synthesis, characterisation, X-ray crystallographic study and nitric oxide related properties (2007) (22)
- New tetradentate Schiff bases, their oxovanadium(IV) complexes, and some complexes of bidentate Schiff bases with vanadium(III) (1997) (22)
- Synthesis, characterisation and speciation studies of heterobimetallic pyridinehydroxamate-bridged Pt(II)/M(II) complexes (M = Cu, Ni, Zn). Crystal structure of a novel heterobimetallic 3-pyridinehydroxamate-bridged Pt(II)/Cu(II) wave-like coordination polymer. (2005) (20)
- Novel palladium(II) and platinum(II) complexes of biocidal benzisothiazolinone (Bit); X-ray crystal structures of co-crystallised Bit/BitO and cis-Pd(en)(Bit−1H)2·H2O (2010) (17)
- Innovative DNA-Targeted Metallo-prodrug Strategy Combining Histone Deacetylase Inhibition with Oxidative Stress. (2018) (16)
- Ruthenium(III) readily abstracts NO from L-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthases. (2001) (15)
- Hydroxamic Acids: An Important Class of Metalloenzyme Inhibitors (2013) (15)
- Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors. (2019) (13)
- New compounds containing thetriangulo-trichlorotrivanadium(II) moiety (1997) (12)
- A novel ruthenium nitrosyl complex which also contains a free NO-donor moiety (2004) (11)
- Derivatisation of buforin IIb, a cationic henicosapeptide, to afford its complexation to platinum(ii) resulting in a novel platinum(ii)-buforin IIb conjugate with anti-cancer activity. (2016) (11)
- The reduction of platinum(IV) and palladium(IV) ions by 2,6-pyridinedihydroxamic acid. (2008) (10)
- Iron(III) Tris(pyridinehydroxamate)s and Related Nickel(II) and Zinc(II) Complexes: Potential Platforms for the Design of Novel Heterodimetallic Supramolecular Assemblies (2007) (9)
- A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties. (2019) (8)
- Hydroxamic Acids: Chemistry, Bioactivity, and Solutionand Solid‐Phase Synthesis (2010) (6)
- Redetermination of fac-tris(benzohydroxamato)iron(III) trihydrate (2000) (6)
- In-vitro cytotoxicity studies of vanadyl complexes with hydroxamic acid series (2010) (5)
- Non-linear optical measurement of Iron(III) Tris(pyridinehydroxamate) complexes (2012) (5)
- Derivatisation of an Anti-Cancer Cationic Antimicrobial Peptide and its Complexation to Platinum(II) (2013) (4)
- CHAPTER 1. Enhancing the Therapeutic Potential of Platinum-based Anticancer Agents by Incorporating Clinically Approved Drugs as Ligands (2019) (3)
- A. Sigel, H. Sigel, R. K. O. Sigel (Eds): Interrelations between essential metal ions and human diseases. Vol. 13 of Metal ions in life sciences (2014) (3)
- "Integrated, interprofessional education for first year undergraduate medical, physiotherapy and pharmacy students" (2011) (1)
- Multi-Targeted Metallo-Ciprofloxacin Derivatives Rationally Designed and Developed to Overcome Antimicrobial Resistance. (2021) (1)
- Book review (2018) (0)
- University of Birmingham A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative — Anti-proliferative and anti-microbial activity (2016) (0)
- Targeted Metallo-Drugs (2023) (0)
- Book review (2020) (0)
This paper list is powered by the following services:
Other Resources About Celine Marmion
What Schools Are Affiliated With Celine Marmion?
Celine Marmion is affiliated with the following schools: